Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial.
Allergy Asthma Clin Immunol
; 16: 8, 2020.
Article
en En
| MEDLINE
| ID: mdl-32042283
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
Idioma:
En
Revista:
Allergy Asthma Clin Immunol
Año:
2020
Tipo del documento:
Article